Compare MDU & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | LGND |
|---|---|---|
| Founded | 1924 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 1994 | N/A |
| Metric | MDU | LGND |
|---|---|---|
| Price | $22.77 | $222.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $21.67 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 1.5M | 188.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,875,066,000.00 | N/A |
| Revenue This Year | $7.52 | $1.25 |
| Revenue Next Year | $6.00 | $19.41 |
| P/E Ratio | ★ $58.36 | $76.27 |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $15.76 | $98.90 |
| 52 Week High | $22.98 | $247.38 |
| Indicator | MDU | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 65.80 | 50.39 |
| Support Level | $20.02 | $180.85 |
| Resistance Level | N/A | $227.92 |
| Average True Range (ATR) | 0.52 | 10.71 |
| MACD | 0.02 | -2.11 |
| Stochastic Oscillator | 86.95 | 46.42 |
MDU Resources Group Inc is a pure-play regulated energy delivery business. It is organized into three reportable business segments: Electric, Natural Gas Distribution, and Pipeline. Maximum revenue is generated from the Pipeline segment, which provides natural gas transportation and underground storage services through a FERC-regulated pipeline system mainly in the Rocky Mountain and northern Great Plains regions of the United States. This segment also provides non-regulated energy-related services, including cathodic protection. The electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming, and the natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.